UTHR Paul A Mahon sells $5.0M worth of shares
Oct 31, 2025, 4:34 AM
0.00%
What does UTHR do
United Therapeutics, based in Silver Spring, Maryland, develops therapies for chronic conditions, primarily focusing on pulmonary arterial hypertension with products like Tyvaso and Remodulin. The company also offers Unituxin for high-risk neuroblastoma and employs 1,168 people.
Paul A Mahon sold 11,000 shares of UTHR on 30 October at $454.15 per share, worth a total of $5.0M. They now own 47,139 UTHR shares, or a 23% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.